Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531
NCT00479349
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
SAM-531
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer